Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients.

Freitas-Alves DR, Vieira-Monteiro HA, Piranda DN, Sobral-Leite M, da Silva TSL, Bergmann A, Valença SS, Perini JA, Vianna-Jorge R.

Endocr Relat Cancer. 2018 Mar;25(3):351-365. doi: 10.1530/ERC-17-0374. Epub 2018 Jan 10.

PMID:
29321183
2.

Modulation of the prostaglandin-endoperoxide synthase 2 gene expression by variant haplotypes: influence of the 3'-untranslated region.

Piranda DN, Abreu RBV, Freitas-Alves DR, de Carvalho MA, Vianna-Jorge R.

Braz J Med Biol Res. 2017 Nov 30;51(2):e6546. doi: 10.1590/1414-431X20176546.

3.

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.

Delou JMA, Vignal GM, Índio-do-Brasil V, Accioly MTS, da Silva TSL, Piranda DN, Sobral-Leite M, de Carvalho MA, Capella MAM, Vianna-Jorge R.

Breast Cancer (Dove Med Press). 2017 Jun 10;9:415-428. doi: 10.2147/BCTT.S131284. eCollection 2017.

4.

Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.

Leite MS, Giacomin LC, Piranda DN, Festa-Vasconcellos JS, Indio-do-Brasil V, Koifman S, de Moura-Neto RS, de Carvalho MA, Vianna-Jorge R.

BMC Cancer. 2014 Mar 14;14:190. doi: 10.1186/1471-2407-14-190.

5.

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R, Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G.

J Exp Med. 2012 Aug 27;209(9):1537-51. doi: 10.1084/jem.20120904. Epub 2012 Aug 13.

6.

The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1.

Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Cresta S, Famà R, Deambrogi C, Greco M, Fangazio M, Ciardullo C, Piranda D, Casaluci GM, Messina M, Giudice ID, Chiaretti S, Marinelli M, Guarini A, Foà R, Gaidano G.

Leuk Suppl. 2012 Aug;1(Suppl 2):S26-8. doi: 10.1038/leusup.2012.16. Epub 2012 Aug 9.

7.

Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.

Capello D, Gloghini A, Baldanzi G, Martini M, Deambrogi C, Lucioni M, Piranda D, Famà R, Graziani A, Spina M, Tirelli U, Paulli M, Larocca LM, Gaidano G, Carbone A, Sinigaglia F.

Hematol Oncol. 2013 Mar;31(1):22-8. doi: 10.1002/hon.2010. Epub 2012 Apr 9.

PMID:
22488585
8.

Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.

Festa-Vasconcellos JS, Piranda DN, Amaral LM, Indio-do-Brasil V, Koifman S, Vianna-Jorge R.

Breast Cancer Res Treat. 2012 Feb;132(1):251-8. doi: 10.1007/s10549-011-1828-0. Epub 2011 Oct 30.

PMID:
22037828
9.

Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study.

Piranda DN, Festa-Vasconcellos JS, Amaral LM, Bergmann A, Vianna-Jorge R.

BMC Cancer. 2010 Nov 8;10:613. doi: 10.1186/1471-2407-10-613.

10.

Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.

Capello D, Deambrogi C, Rossi D, Lischetti T, Piranda D, Cerri M, Spina V, Rasi S, Gaidano G, Lunghi M.

Br J Haematol. 2008 May;141(4):504-11. doi: 10.1111/j.1365-2141.2008.07072.x. Epub 2008 Mar 3.

PMID:
18318760
11.

Role of p38 map kinase in glycine-induced hepatocyte resistance to hypoxic injury.

Carini R, Alchera E, Baldanzi G, Piranda D, Splendore R, Grazia De Cesaris M, Caraceni P, Graziani A, Albano E.

J Hepatol. 2007 Apr;46(4):692-9. Epub 2006 Nov 27.

PMID:
17188389
12.

Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia.

Carini R, Alchera E, De Cesaris MG, Splendore R, Piranda D, Baldanzi G, Albano E.

J Hepatol. 2006 Aug;45(2):236-45. Epub 2006 Apr 6.

PMID:
16644060
13.

Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase.

Moro L, Reineri S, Piranda D, Pietrapiana D, Lova P, Bertoni A, Graziani A, Defilippi P, Canobbio I, Torti M, Sinigaglia F.

Blood. 2005 Jan 1;105(1):115-21. Epub 2004 Jun 15.

Supplemental Content

Loading ...
Support Center